Sunshine Biopharma Inc (SBFM)

[TraderAI]

Investors pretty much have nailed SBFM down pat. So now we know this:

A) If they got nothing to offer in 5 months, they will do a huge reverse split somewhere between 10 to 30 cents.

Or

B) Somehow if they get this to a buck, they still must meet analyst expectations. Remember David Bouchery of AEGIS? He is ranked 8150 out of 8190 analyst. He’s right 12% of the time.

He put this at $2.60 and then $3.00. Imagine betting against him and winning 88% of the time!

So they need something substantially huge (somewhere in the $50 to 100M range) to move the needle or..

Reverse Split.